NO20035224D0 - Oftalmisk pirenzepingel - Google Patents

Oftalmisk pirenzepingel

Info

Publication number: NO20035224D0
Authority: NO; Norway
Prior art keywords: pirenzepel; ophthalmic; ophthalmic pirenzepel
Prior art date: 2001-05-25

Application number

NO20035224A

Other languages

English (en)

Inventor

Harun Takruri

Original Assignee

Valley Forge Pharmaceuticals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-25

Filing date

2003-11-24

Publication date

2003-11-24

2003-11-24 Application filed by Valley Forge Pharmaceuticals filed Critical Valley Forge Pharmaceuticals

2003-11-24 Publication of NO20035224D0 publication Critical patent/NO20035224D0/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20035224A 2001-05-25 2003-11-24 Oftalmisk pirenzepingel NO20035224D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29373101P	2001-05-25	2001-05-25
PCT/US2002/013823 WO2002096418A1 (en)	2001-05-25	2002-05-01	Pirenzepine ophthalmic gel

Publications (1)

Publication Number	Publication Date
NO20035224D0 true NO20035224D0 (no)	2003-11-24

Family

ID=23130330

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20035224A NO20035224D0 (no)	2001-05-25	2003-11-24	Oftalmisk pirenzepingel

Country Status (17)

Country	Link
US (2)	US20040137069A1 (no)
EP (1)	EP1397132A4 (no)
JP (1)	JP2004531569A (no)
KR (1)	KR20040018380A (no)
CN (1)	CN1509172A (no)
BR (1)	BR0210013A (no)
CA (1)	CA2447562A1 (no)
EC (1)	ECSP044862A (no)
HU (1)	HUP0304071A2 (no)
IL (1)	IL158904A0 (no)
MX (1)	MXPA03010655A (no)
NO (1)	NO20035224D0 (no)
NZ (1)	NZ529615A (no)
PL (1)	PL366924A1 (no)
RU (1)	RU2297831C2 (no)
WO (1)	WO2002096418A1 (no)
ZA (1)	ZA200309791B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8466144B2 (en)	2004-07-16	2013-06-18	Proteosys Ag	Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents
JP4963359B2 (ja) *	2005-01-12	2012-06-27	ロート製薬株式会社	眼局所適用製剤
JP2010514517A (ja) *	2006-12-26	2010-05-06	キューエルティープラグデリバリー，インク．	視覚欠損の抑制のための薬物送達インプラント
US10265265B2 (en)	2007-03-15	2019-04-23	Drug Delivery Solutions Limited	Topical composition
EP2008651A1 (en)	2007-06-26	2008-12-31	Drug Delivery Solutions Limited	A bioerodible patch
NZ583678A (en)	2007-09-07	2012-03-30	Quadra Logic Tech Inc	Silicone matrix drug cores for sustained release of therapeutic agents
US8883214B2 (en)	2009-01-13	2014-11-11	The Regents Of The University Of California	Implantable delivery vehicle for ocular delivery of muscarinic antagonists
PL2632468T3 (pl) *	2010-10-25	2018-04-30	University Of Manitoba	Kompozycje terapeutyczne do leczenia symetrycznej polineuropatii cukrzycowej
PT2686017T (pt)	2011-03-14	2019-10-24	Drug Delivery Solutions Ltd	Uma composição oftálmica.
RU2635185C2 (ru) *	2013-12-17	2017-11-09	Иван Дмитриевич Захаров	Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости
US9421199B2 (en)	2014-06-24	2016-08-23	Sydnexis, Inc.	Ophthalmic composition
WO2016172712A2 (en)	2015-04-23	2016-10-27	Sydnexis, Inc.	Ophthalmic composition
US11382909B2 (en)	2014-09-05	2022-07-12	Sydnexis, Inc.	Ophthalmic composition
EP3302426A4 (en)	2015-05-29	2018-12-05	Sydnexis, Inc.	D2o stabilized pharmaceutical formulations
CN105663137A (zh) *	2016-01-14	2016-06-15	王真	哌仑西平在制备治疗脓毒症疾病的药物中的应用
KR20230141882A (ko) *	2016-05-25	2023-10-10	싱가포르 헬스 서비시즈 피티이 엘티디	아트로핀-함유 수성 조성물
AU2018362010B2 (en)	2017-11-03	2021-05-13	Alcon Inc.	Azabicyclo and diazepine derivatives for treating ocular disorders
EP3542788A1 (en)	2018-03-19	2019-09-25	MC2 Therapeutics Limited	Topical composition comprising calcipotriol and betamethasone dipropionate
SG11202110342UA (en) *	2019-03-26	2021-10-28	Winsantor Inc	Topical formulations for treatment of peripheral neuropathies
JP2022536460A (ja) *	2019-06-10	2022-08-17	ジェニヴィジョンインク．	視力障害を治療するための方法及び製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU188852B (en) *	1983-03-16	1986-05-28	Richter Gedeon Vegyeszeti Gyar Rt,Hu	Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
US4865599A (en) *	1986-08-18	1989-09-12	Houston Biotechnology, Inc.	Ophthalmic compositions for treating nerve degeneration
CA1336490C (en) *	1988-06-03	1995-08-01	Paul Michael Iuvone	Pharmacological treatment of ocular development
US5122522A (en) *	1989-06-21	1992-06-16	The Trustees Of The University Of Pennsylvania	Treatment and control of ocular development
US5360801A (en) *	1989-06-21	1994-11-01	The Trustees Of The University Of Pennsylvania	Pharmacological stimulation of eye growth
DE69033246T2 (de) *	1989-06-21	1999-12-02	Univ Pennsylvania	Behandlung und Regulierung der Augenentwicklung mit cholinergischen Agonisten
US5055302A (en) *	1990-02-22	1991-10-08	Trustees Of The University Of Pennsylvania	Neuropeptide control of ocular growth
US5461808A (en) *	1993-02-08	1995-10-31	Fritts; Robert W.	Table top backlit display
US5461052A (en) *	1993-04-30	1995-10-24	The Trustees Of The University Of Pennsylvania	Prevention of myopia by tricyclic compounds
US5385939A (en) *	1993-04-30	1995-01-31	The Trustees Of The University Of Pennsylvania	GABA-ergic modulation of eye growth
US5516808A (en) *	1994-10-27	1996-05-14	Sawaya; Assad S.	Topical cellulose pharmaceutical formulation
US5888493A (en) *	1996-12-05	1999-03-30	Sawaya; Assad S.	Ophthalmic aqueous gel formulation and related methods
US6164282A (en) *	1999-01-27	2000-12-26	Allergan Sales, Inc.	Methods for restoring and/or enhancing accommodation in pseudo phakia

2002
- 2002-05-01 EP EP02734130A patent/EP1397132A4/en not_active Withdrawn
- 2002-05-01 HU HU0304071A patent/HUP0304071A2/hu unknown
- 2002-05-01 CN CNA02810174XA patent/CN1509172A/zh active Pending
- 2002-05-01 PL PL02366924A patent/PL366924A1/xx not_active Application Discontinuation
- 2002-05-01 KR KR10-2003-7015393A patent/KR20040018380A/ko not_active Application Discontinuation
- 2002-05-01 RU RU2003136735/15A patent/RU2297831C2/ru not_active IP Right Cessation
- 2002-05-01 MX MXPA03010655A patent/MXPA03010655A/es not_active Application Discontinuation
- 2002-05-01 BR BR0210013-4A patent/BR0210013A/pt not_active IP Right Cessation
- 2002-05-01 JP JP2002592928A patent/JP2004531569A/ja not_active Withdrawn
- 2002-05-01 CA CA002447562A patent/CA2447562A1/en not_active Abandoned
- 2002-05-01 WO PCT/US2002/013823 patent/WO2002096418A1/en active IP Right Grant
- 2002-05-01 NZ NZ529615A patent/NZ529615A/en unknown
- 2002-05-01 IL IL15890402A patent/IL158904A0/xx unknown
2003
- 2003-10-31 US US10/698,320 patent/US20040137069A1/en not_active Abandoned
- 2003-11-24 NO NO20035224A patent/NO20035224D0/no not_active Application Discontinuation
- 2003-12-18 ZA ZA200309791A patent/ZA200309791B/xx unknown
2004
- 2004-01-23 EC EC2004004862A patent/ECSP044862A/es unknown
2006
- 2006-04-07 US US11/400,635 patent/US20060188576A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20040137069A1 (en)	2004-07-15
EP1397132A1 (en)	2004-03-17
US20060188576A1 (en)	2006-08-24
MXPA03010655A (es)	2007-06-22
IL158904A0 (en)	2004-05-12
EP1397132A4 (en)	2006-12-13
ZA200309791B (en)	2004-10-04
ECSP044862A (es)	2004-03-23
KR20040018380A (ko)	2004-03-03
RU2003136735A (ru)	2005-03-27
HUP0304071A2 (hu)	2004-04-28
CN1509172A (zh)	2004-06-30
WO2002096418A1 (en)	2002-12-05
NZ529615A (en)	2005-07-29
JP2004531569A (ja)	2004-10-14
RU2297831C2 (ru)	2007-04-27
CA2447562A1 (en)	2002-12-05
BR0210013A (pt)	2004-08-10
PL366924A1 (en)	2005-02-07

Legal Events

Date	Code	Title	Description
2008-01-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DE50204184D1 (de)	2005-10-13	Espressobrüheinrichtung
ATE524462T1 (de)	2011-09-15	C5-modifizierte indazolylpyrrolotriazine
DE50208022D1 (de)	2006-10-12	Wischblatt
DE50206021D1 (de)	2006-05-04	Schlauchklemme
DE50103741D1 (de)	2004-10-28	Welle-Nabe-Verbindung
DE50204386D1 (de)	2006-02-09	Kreuztransducer
DE60225606D1 (de)	2008-04-24	Perfluoroelastomere
DE50209238D1 (de)	2007-02-22	Kugelgelenk
NO20035224D0 (no)	2003-11-24	Oftalmisk pirenzepingel
DE1319930T1 (de)	2003-11-27	Coriolismassendurchflussmesser
DE50209410D1 (de)	2007-03-22	Kugelgelenk
NO20014597D0 (no)	2001-09-21	Fremgangsmåte
DE50204551D1 (de)	2005-11-17	Kugelgelenk
DE50208372D1 (de)	2006-11-23	Schrankaufhängevorrichtung
DE50203984D1 (de)	2005-09-22	Kugelgelenk
DE50203412D1 (de)	2005-07-21	Schwenkkolbenverdränger
DE50204794D1 (de)	2005-12-08	Kugelgelenk
DE50208029D1 (de)	2006-10-12	Kugelgelenk
ATE355059T1 (de)	2006-03-15	Isoxazolopyridinone
DE50201862D1 (de)	2005-01-27	Messwandler
DE50203093D1 (de)	2005-06-16	Losradlager
DE50209293D1 (de)	2007-03-08	Amidpolymermasse
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
DE50209386D1 (de)	2007-03-15	Kugelgelenk
DE50207815D1 (de)	2006-09-21	Kugelgelenk